No abstract available
MeSH terms
-
Clinical Trials, Phase II as Topic / trends
-
Clinical Trials, Phase III as Topic / trends
-
Drug Discovery / trends*
-
Humans
-
Immunologic Factors / therapeutic use*
-
Multiple Sclerosis, Relapsing-Remitting / pathology
-
Multiple Sclerosis, Relapsing-Remitting / prevention & control*
-
Neuroprotective Agents / therapeutic use*
Substances
-
Immunologic Factors
-
Neuroprotective Agents